Featured Research

from universities, journals, and other organizations

New technique to study how myeloids become white blood cells

Date:
October 25, 2012
Source:
School of Molecular and Cellular Biology, University of Illinois, Urbana
Summary:
Researchers have created a new technique to study how myeloids, a type of blood stem cell, become the white blood cells important for immune system defense against infections and tissue damage. This approach offers new insights into the molecular mechanisms at work during myeloid differentiation, and may improve our ability to treat myeloid diseases like leukemia, the researchers report.

Dr. Fei Wang and the co-corresponding author Dr. Dong Li.
Credit: Image courtesy of School of Molecular and Cellular Biology, University of Illinois, Urbana

Associate Professor of Cell and Developmental Biology Fei Wang and colleagues have created a new technique to study how myeloids, a type of blood stem cell, become the white blood cells important for immune system defense against infections and tissue damage. This tool provides an improved understanding of the molecular mechanisms at work during this myeloid differentiation process, and may improve our ability to treat myeloid diseases like leukemia.

Their findings appear in the journal Blood.

Myeloids are blood stem cells from bone marrow or the spinal cord that are turned into common types of white blood cells like neutrophils and macrophages through the process of myeloid differentiation. Deficiencies in this differentiation process cause leukemia, or cancer of the white blood cells. Researchers in the field had previously studied myeloid differentiation using two types of cell systems. In one method of study, scientists performed experiments using primary cells, or those cells taken directly from animals. Scientists have also utilized leukemia tumor cells in this research by returning them to their previous myeloid stem cell-like states. However, primary cells are hard to grow and manipulate genetically, and tumor cells still contain the genetic mutations that caused these cells to divide uncontrollably in the first place.

The drawbacks of these systems prompted Associate Professor of Cell and Developmental Biology and corresponding author Fei Wang to develop a different system to better understand the mechanisms of myeloid differentiation. Wang and his team began by turning mouse embryonic stem cells into myeloid progenitor cells. They then added a protein called Hoxb8 to these cells that had been shown previously to immortalize myeloid progenitor cells so that they do not die and grow indefinitely.

"This really simplified the whole system, so, number one, we didn't have to deal with animals or human bodies, and, number two, we immortalized these cells so that they can be easily handled in culture and maintain normal myeloid progenitor cell genetic information," Wang said.

The researchers wanted to prove that their model is effective in determining the molecular mechanisms important to myeloid differentiation. Enzymes called protein kinases are known to mediate processes like cell development, immune response, and cell differentiation. They screened a variety of protein kinase inhibitors to find potential key regulators of myeloid differentiation. A protein kinase inhibitor of a molecule called mTor, a master regulator of cell behavior, was found to interfere with myeloid differentiation, signifying that mTor is a key regulator of this process. A variety of experiments were performed both inside and outside the mouse body with mTor to further prove that this molecule is necessary for myeloid differentiation.

"The function of this molecule had not been defined prior to this study in the context of myeloid differentiation," Wang said, "This is the first evidence showing that this molecule plays a significant role in myeloid differentiation." This finding serves as a proof of principle that the new system provides a powerful tool for future studies of normal and abnormal myeloid differentiation. "Using this system, we can introduce genetic manipulations that tell us something very important about how normal myeloid differentiation works, and what kind of molecular events in this process can go wrong, leading to diseases like leukemia," Wang said.

"People can use this as a platform for large-scale screening analysis for drugs that potentially can promote myeloid differentiation and can slow down or stop myeloid disease processes."


Story Source:

The above story is based on materials provided by School of Molecular and Cellular Biology, University of Illinois, Urbana. The original article was written by Chelsey Coombs. Note: Materials may be edited for content and length.


Journal Reference:

  1. D. Li, H. Yang, H. Nan, P. Liu, S. Pang, Q. Zhao, R. Karni, M. P. Kamps, Y. Xu, J. Zhou, T. Wiedmer, P. J. Sims, F. Wang. Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model. Blood, 2012; DOI: 10.1182/blood-2012-03-414979

Cite This Page:

School of Molecular and Cellular Biology, University of Illinois, Urbana. "New technique to study how myeloids become white blood cells." ScienceDaily. ScienceDaily, 25 October 2012. <www.sciencedaily.com/releases/2012/10/121025130912.htm>.
School of Molecular and Cellular Biology, University of Illinois, Urbana. (2012, October 25). New technique to study how myeloids become white blood cells. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2012/10/121025130912.htm
School of Molecular and Cellular Biology, University of Illinois, Urbana. "New technique to study how myeloids become white blood cells." ScienceDaily. www.sciencedaily.com/releases/2012/10/121025130912.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins